Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA

Caffeine is considered to be a neuroprotective agent against Parkinson's disease (PD) and is expected to offer a blood-based biomarker for the disease. We herein investigated the ability of this biomarker to discriminate between PD and neurodegenerative diseases. To quantify caffeine concentrat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Neurol
Main Authors: Ohmichi, Takuma, Kasai, Takashi, Shinomoto, Makiko, Matsuura, Jun, Koizumi, Takashi, Kitani-Morii, Fukiko, Tatebe, Harutsugu, Sasaki, Hidenao, Mizuno, Toshiki, Tokuda, Takahiko
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Neurology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783046/
https://ncbi.nlm.nih.gov/pubmed/33414755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.580127
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares